By Ben Hirschler
LONDON |
Thu Oct 31, 2013 11:04am EDT
LONDON (Reuters) – AstraZeneca is being investigated by U.S. authorities over a major clinical trial that was used to win marketing approval for its new heart drug Brilinta, casting fresh doubts over the…
U.S. authorities quiz AstraZeneca over heart drug trial
No comments:
Post a Comment